Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CHRD | IDA |
|---|---|---|
| Price | $139.11 | $131.73 |
| Change today | ▲ 1.53% | ▼ 0.80% |
| Market cap | $7.61B | $7.62B |
| Return, 3 months | +20.1% | -12.6% |
| Return, year to date | +54.3% | +6.1% |
| Return, 1 year | +45.6% | +1.1% |
| P/E (TTM) | 9.4 | 21.8 |
| P/B | 0.9 | 2.0 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 3.74% | 2.66% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 47 | 44 |
| 30-day volatility | 34.7% | 14.4% |
| Max drawdown, 1 year | -24.8% | -16.9% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
